Halozyme Therapeutics, Inc. SEC filings HALO

Halozyme Therapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Dec 12, 2011. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Halozyme Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Sep 30, 2026 Sep 28, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 22, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 18, 2026 Sep 17, 2026
8-K Current report
Other events
Sep 16, 2026 Sep 16, 2026
8-K Current report
Officer or director change
Aug 18, 2026 Aug 14, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 2, 2026 Jun 30, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
8-K Current report
Shareholder vote results
May 7, 2026 May 5, 2026
8-K Current report
Officer or director change
Apr 30, 2026 Apr 30, 2026
8-K Current report
Bylaw or fiscal year change
Apr 24, 2026 Apr 22, 2026
ARS Annual report to shareholders Mar 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 23, 2026 —
DEF 14A Proxy statement Mar 23, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Mar 12, 2026 Mar 12, 2026
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
8-K Current report
Results of operations
Jan 28, 2026 Jan 28, 2026
8-K Current report
Officer or director change
Dec 9, 2025 Dec 4, 2025
8-K Current report
Officer or director change
Dec 8, 2025 Dec 4, 2025
8-K Current report
Officer or director change
Nov 24, 2025 Nov 18, 2025
S-8 Employee stock plan registration Nov 18, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 12, 2025 Nov 6, 2025
8-K Current report
Other events
Nov 7, 2025 Nov 6, 2025
8-K Current report
Material agreement, New debt, Other events
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change
Nov 3, 2025 Nov 3, 2025
8-K Current report
Regulation FD disclosure
Oct 14, 2025 Oct 14, 2025
8-K Current report
Officer or director change
Oct 6, 2025 Oct 1, 2025
8-K Current report
Material agreement
Oct 3, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Oct 1, 2025 Sep 30, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Shareholder vote results
May 2, 2025 May 1, 2025
8-K Current report
Officer or director change
Mar 21, 2025 Mar 17, 2025
ARS Annual report to shareholders Mar 18, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 18, 2025 —
DEF 14A Proxy statement Mar 18, 2025 Dec 31, 2024
10-K Annual report Feb 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 18, 2025 Feb 18, 2025
8-K Current report
Officer or director change
Feb 13, 2025 Feb 11, 2025
8-K Current report
Results of operations
Jan 8, 2025 Jan 8, 2025
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Shareholder vote results
Apr 26, 2024 Apr 25, 2024
ARS Annual report to shareholders Mar 15, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 15, 2024 —
DEF 14A Proxy statement Mar 15, 2024 Dec 31, 2023
PRE 14A Preliminary proxy statement Mar 4, 2024 Dec 31, 2023
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
8-K Current report
Results of operations
Jan 17, 2024 Jan 17, 2024
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 6, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
UPLOAD Letter from the SEC Jul 21, 2023 —
CORRESP Letter to the SEC Jun 28, 2023 —
UPLOAD Letter from the SEC Jun 14, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Shareholder vote results
May 8, 2023 May 5, 2023
ARS Annual report to shareholders Mar 24, 2023 Dec 31, 2022
DEFA14A Additional proxy material Mar 24, 2023 —
DEF 14A Proxy statement Mar 24, 2023 —
8-K Current report
Regulation FD disclosure
Mar 16, 2023 Mar 15, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 10, 2023
8-K Current report
Officer or director change
Feb 23, 2023 Feb 22, 2023
10-K Annual report Feb 21, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 21, 2023 Feb 21, 2023
8-K Current report
Officer or director change
Feb 6, 2023 Feb 3, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Material agreement, New debt
Aug 19, 2022 Aug 18, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 18, 2022 Aug 15, 2022
8-K Current report
Other events
Aug 16, 2022 Aug 15, 2022
8-K Current report
Other events
Aug 15, 2022 Aug 15, 2022
8-K/A Amended current report Aug 9, 2022 May 24, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
May 24, 2022 May 24, 2022
SC TO-T/A Filing May 24, 2022 —
SC TO-T/A Filing May 12, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
8-K Current report
Shareholder vote results
May 6, 2022 May 5, 2022
SC TO-T/A Filing May 2, 2022 —
SC TO-T Filing Apr 26, 2022 —
DEFA14A Additional proxy material Apr 18, 2022 —
SC TO-C Filing Apr 14, 2022 —
SC TO-C Filing Apr 13, 2022 —
SC TO-C Filing Apr 13, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 13, 2022 Apr 12, 2022
DEFA14A Additional proxy material Mar 25, 2022 —
DEF 14A Proxy statement Mar 25, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Mar 21, 2022 Mar 16, 2022
8-K Current report
Officer or director change
Mar 15, 2022 Mar 15, 2022
10-K Annual report Feb 22, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 22, 2022 Feb 22, 2022
8-K Current report
Officer or director change
Feb 3, 2022 Feb 2, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Material agreement, New debt
Dec 29, 2021 Dec 23, 2021
8-K Current report
Officer or director change
Dec 13, 2021 Dec 13, 2021
8-K Current report
Bylaw or fiscal year change
Dec 10, 2021 Dec 8, 2021
8-K/A Amended current report
Results of operations
Nov 2, 2021 Nov 2, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Acquisition or sale of assets
Nov 2, 2021 Nov 2, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
8-K Current report
Shareholder vote results
May 7, 2021 May 5, 2021
S-8 Employee stock plan registration May 5, 2021 —
S-8 Employee stock plan registration May 5, 2021 —
8-K Current report
Officer or director change
May 5, 2021 May 5, 2021
8-K Current report
Officer or director change
May 3, 2021 May 1, 2021
DEFA14A Additional proxy material Mar 26, 2021 —
DEF 14A Proxy statement Mar 26, 2021 Dec 31, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 1, 2021 Mar 1, 2021
8-K Current report
Other events
Feb 25, 2021 Feb 24, 2021
8-K Current report
Other events
Feb 23, 2021 Feb 23, 2021
10-K Annual report Feb 23, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 23, 2021 Feb 23, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2021 Jan 13, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 11, 2021
10-Q Quarterly report Nov 2, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 2, 2020 Nov 2, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
8-K Current report
Shareholder vote results
May 4, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 3, 2020 —
DEFA14A Additional proxy material Mar 20, 2020 —
DEF 14A Proxy statement Mar 20, 2020 Dec 31, 2019
10-K Annual report Feb 24, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Feb 24, 2020 Feb 18, 2020
8-K Current report
Results of operations
Feb 24, 2020 Feb 24, 2020
8-K Current report
Regulation FD disclosure
Jan 16, 2020 Jan 16, 2020
8-K Current report
Results of operations
Jan 14, 2020 Jan 14, 2020
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Nov 18, 2019 Nov 18, 2019
8-K Current report
Other events
Nov 14, 2019 Nov 13, 2019
8-K/A Amended current report
Exit or restructuring costs, Impairment
Nov 12, 2019 Oct 30, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Other events
Nov 12, 2019 Nov 12, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Exit or restructuring costs, Impairment, Officer or director change
Nov 5, 2019 Oct 30, 2019
8-K Current report
Regulation FD disclosure
Sep 4, 2019 Sep 4, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Other events
Jun 12, 2019 Jun 12, 2019
S-8 POS 2005 and 2006 plan deregistration May 14, 2019 —
S-8 POS 2004 plan deregistration May 14, 2019 —
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 3, 2019 May 2, 2019
DEFA14A Additional proxy material Mar 22, 2019 —
DEF 14A Proxy statement Mar 22, 2019 Dec 31, 2018
PRE 14A Preliminary proxy statement Mar 1, 2019 Dec 31, 2018
10-K Annual report Feb 21, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 21, 2019 Feb 21, 2019
8-K Current report
Regulation FD disclosure
Jan 9, 2019 Jan 9, 2019
CT ORDER Filing Dec 20, 2018 —
8-K Current report
Officer or director change
Dec 13, 2018 Dec 12, 2018
8-K Current report
Other events
Nov 26, 2018 Nov 26, 2018
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
8-K Current report
Officer or director change
Sep 10, 2018 Sep 7, 2018
8-K Current report
Regulation FD disclosure
Sep 5, 2018 Sep 5, 2018
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
S-8 Employee stock plan registration May 10, 2018 —
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 10, 2018 May 10, 2018
8-K Current report
Shareholder vote results
May 2, 2018 May 2, 2018
8-K Current report
Officer or director change, Other events
Apr 6, 2018 Apr 5, 2018
DEFA14A Additional proxy material Apr 6, 2018 —
DEFA14A Additional proxy material Apr 3, 2018 —
DEFA14A Additional proxy material Mar 22, 2018 —
DEF 14A Proxy statement Mar 22, 2018 Dec 31, 2017
8-K Current report
Officer or director change
Mar 22, 2018 Mar 20, 2018
10-K Annual report Feb 20, 2018 Dec 31, 2017
8-K Current report
Results of operations
Feb 20, 2018 Feb 20, 2018
8-K Current report
Results of operations
Jan 12, 2018 Jan 9, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2018 Jan 9, 2018
10-Q Quarterly report Nov 7, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 7, 2017 Nov 7, 2017
8-K Current report
Officer or director change
Sep 29, 2017 Sep 29, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
HALO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1159036
Former names
HALOZYME THERAPEUTICS INC (until Jul 3, 2019); GLOBAL YACHT SERVICES INC (until Mar 12, 2004)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.